glp 1 blind GLP-1 medications are transforming how many millions of people manage obesity and diabetes How GLP-1 drugs are disrupting

Bottom Line GLP-1 agonists have a place in medicine as treatment for Type 2 diabetes and obesity, offering benefits in blood sugar control and weight loss

Researchers have observed that peptide analogs may significantly increase MMP activity while attenuating the activation of -smooth muscle actin (-SMA) and cyclooxygenase-2 (COX-2), markers associated with inflammation and fibrogenesis

Simultaneous initiation may offer comprehensive benefits by targeting multiple pathogenic pathways early in treatment

Department of Agriculture (USDA NIFA 2010-03741)

Although consensus is still evolving, several key themes have emerged

Theyre quick, easy to sip, and tailored to the days when your appetite just isnt there